ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells.

Zhuo Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.